1,050
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Ecology of Candida-associated Denture Stomatitis

Pages 170-185 | Published online: 11 Jul 2009

References

  • Marsch PD, Percival RS, Challacombe SJ. The influence of denture-wearing and age on the oral microflora. J Dent Res 1992; 71: 1374–81.
  • Socransky SS, Manganiello SD. The oral microbiota of man from birth to senility. J Periodontol 1971; 42: 485–96.
  • Percival RS, Challacombe SJ, Marsch PD. Age-related microbiological changes in the salivary and plaque microflora of healthy adults. J Med Microbiol 1991; 35: 5–11.
  • Cahn LR. The denture sore mouth. Ann Dent 1936; 3: 33–6.
  • Marples MJ, Di Menna ME. The incidence of Candida albicans in Dunedin, New Zealand. J Pathol Bact 1952; 64: 497–502.
  • Lilienthal B. Studies of the flora of the mouth: III. Yeast-like organisms: some observations on their incidence in the mouth. Aust J Exp Biol Med Sci 1950; 28: 279–86.
  • Budtz-Jorgensen E. The significance of Candida albicans in denture stomatitis. Scand J Dent Res 1974; 82: 151–90.
  • Bergendal T. Treatment of denture stomatitis. A clinical, microbiological and histological evaluation. Thesis, Stock-holm, Sweden, 1982.
  • Kaaber S. The permeability and barrier functions of the oral mucosa with respect to water and electrolytes. Acta Odontol Scand 1974; 32: Suppl 66: 1–47.
  • Riber E, Kaaber S. Barrier properties of inflamed denture loaded mucosa to water. Scand J Dent Res 1978; 86: 386–91.
  • Budtz-Jorgensen E. Denture Stomatitis. V. Candida agglutinins in human sera. Acta Odontol Scand 1972; 30: 313–25.
  • Olsen I. Studies on oral yeast infections with emphasis on denture stomatitis. Thesis, Oslo, Norway, 1976.
  • Martin MV, Craig GT, Lamb DJ. An investigation of the role of true hyphae production in the pathogenesis of exper-imental oral candidosis. Sabouraudia 1984; 22: 471–6.
  • Budtz-Jorgensen E, Theilade E, Theilade J. Quantitative relationship between yeasts and bacteria in denture-induced stomatitis. Scand J Dent Res 1983; 91: 134–42.
  • Fouche MH, Slabbert JCG, Coogan MM. Bacterial antibodies in patients undergoing treatment for denture stomatitis. J Prosthet Dent 1987; 58: 63–8.
  • Budtz-Jorgensen E. Denture stomatitis. IV. An experimental model in monkeys. Acta Odontol Scand 1971; 29: 513–26.
  • Bartels HA. Local and systemic factors in oral moniliasis. NY J Dent 1965; 35: 283–5.
  • Olsen I, Haanaes HR. Experimental palatal candidosis and saliva flow in monkeys. Scand J Dent Res 1977; 85: 135–41.
  • Budtz-Jorgensen E, Theilade E, Theilade J, Zander HA. Method for studying the development, structure and mi-croflora of denture plaque. Scand J Dent Res 1981; 89: 149–56.
  • Theilade J, Budtz-Jorgensen E. Electron microscopic study of denture plaque. J Biol Buccale 1980; 8: 287–97.
  • Gusberti FA, Gada TG, Lang NP, Geering AH. Cultivable microflora of plaque from full denture bases and adjacent palatal mucosa. J Biol Buccale 1985; 13: 227–36.
  • Theilade J. Development of bacterial plaque in the oral cavity. J Clin Periodontol 1977; 4: 1–12.
  • Theilade E, Budtz-Jorgensen E, Theilade J. Predominant cultivable microflora of plaque on removable dentures in patients with healthy oral mucosa. Archs Oral Biol 1983; 28: 675–80.
  • Carlsson J, Soderholm G, Almfield I. Prevalence of Strepto-coccus sanguis and Streptococcus mutans in the mouth of persons wearing full dentures. Archs Oral Biol 1969; 14: 243–9.
  • Könönen E, Asikainen S, Alaluusua S, et al. Are certain oral pathogens part of normal oral flora in dendure-wearing edentulous subjects? Oral Microbiol Immunol 1991; 6: 119–22.
  • Budtz-Jorgensen E, Stenderup A, Grabowski M. An epidemiologic study of yeasts in elderly denture wearers. Com-munity Dent Oral Epidemiol 1975; 3: 115–9.
  • Theilade E, Budtz-Jorgensen E. Predominant cultivable microflora of plaque on removable dentures in patients with denture-induced stomatitis. Oral Microbiol Immunol 1988; 3: 8–13.
  • Koopmans ASF, Kippuw N, de Graaf J. Bacterial involvement in denture-induced stomatitis. J Dent Res 1988; 67: 1246–50.
  • Budtz-Jorgensen E, Theilade E. Regional variations in viable bacterial and yeast counts of 1-week-old denture plaque in denture-induced stomatitis. Scand J Dent Res 1983; 91: 288–95.
  • Budtz-Jorgensen E, Bertram U. Denture stomatitis. I. The etiology in relation to trauma and infection. Acta Odontol Scand 1970; 46: 267–72.
  • Davenport JC. The oral distribution of Candida in denture stomatitis. Br Dent J 1970; 129: 151–6.
  • Budtz-Jorgensen E. Evaluation of a dehydrated test strip, Microstie-Candida, for detection of Candida-induced den-ture stomatitis. Scand J Dent Res 1976; 84: 229–33.
  • Arendorf T, Walker DM. Oral candidal populations in health and disease. Br Dent J 1979; 147: 267–72.
  • Bergendal T, Holmberg K, Nord CE. Yeast colonization in the oral cavity and faeces in patients with denture stomatitis. Acta Odontol Scand 1979; 37: 37–45.
  • Axell T, Simonsson T, Birkhed D, Rosenborg J, Edwardsson S. Evaluation of a simplified diagnostic aid (Oricult-N) for detection of oral candidosis. Scand J Dent Res 1985; 93: 52–5.
  • Brown LR, Merrill SS, Lambson GO. Microbiologic aspects of papillary hyperplasia. Oral Surg Oral Med Oral Pathol 1969; 28: 545–51.
  • Van Reenen JF. Microbiologic studies on denture stomatitis. J Prosthet Dent 1973; 30: 493–505.
  • Renner RP, Lee M, Andors L, McNamara TF. The role of C. albicans in denture stomatitis. Oral Surg Oral Med Oral Pathol 1979; 47: 323–8.
  • Fouche MH, Slabbert JCG, Coogan MM. Microorganisms isolated from patients with denture stomatitis. J Dent Assoc Sth Afr 1986; 41: 313–6.
  • Catalan A, Herrera R, Martinez A. Denture plaque and palatal mucosa in denture stomatitis: Scanning electron mi-croscopic and microbiologic study. J Prosthet Dent 1987; 57: 581–6.
  • Frank RM, Steuer P. Transmission electron microscopy of plaque accumulations in denture stomatitis. J Prosthet Dent 1985; 53: 115–24.
  • Zgraggen U, Graf H. pH-Veränderungen unter Oberkiefer-vollprothesen. Schweiz Monaschr Zahnmed 1975; 85: 797–812.
  • Olsen I, Birkeland JM. Initiation and aggravation of denture stomatitis by sucrose rinses. Scand J Dent Res 1976; 84: 94–7.
  • Walter B, Frank RM, Steuer P. Ultrastructural development of dated plaque in case of denture stomatitis. J Biol Buccale 1986; 14: 115–24.
  • Walker DM, Stafford GD, Huggett R, Newcombe RG. The treatment of denture-induced stomatitis. Evaluation of two agents. Br Dent J 1981; 151: 416–9.
  • Schou L, Wright C, Cumming C. Oral hygiene habits, denture plaque, presence of yeasts and stomatitis in institu-tionalised elderly in Lothian, Scotland. Community Dent Oral Epidemiol 1987; 15: 85–9.
  • Vigild M. Oral mucosal lesions among institutionalized elderly in Denmark. Community Dent Oral Epidemiol 1987; 15: 309–13.
  • Bergendal T. Status and treatment of denture stomatitis patients. Scand J Dent Res 1982; 90: 227–38.
  • Koopmans ASF, Sillevis Smitt PAE, Kalk W, de Graff J. Efficacy of 2.5% Pimafucin suspension in the treatment of denture stomatitis. J Prosthet Dent 1984; 51: 461–6.
  • Budtz-Jorgensen E, Mojon P, Banon-Clement JM, Baehni P. Oral candidosis in long-term hospital care: comparison of edentulous and dentate subjects. Oral Dis 1996; 2: 285–90.
  • Budtz-Jorgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 1990; 48: 61–9.
  • MacFarlane TW. Ecology and epidemiology of Candida. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis. Bristol, UK: Wright, 1990: 21–46.
  • Krogh P, Hald B, Holmstrup P. Possible mycological aetiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in the production of N-nitrosobenzylmethylamine. Carcinogenesis 1987; 8: 1543–8.
  • Budtz-Jorgensen E, Mojon P, Rentsch A, Deslauriers N. Effects of an oral health program on the occurrence of oral candidosis in a long-term care facility. Community Dent Oral Epidemiol 2000; 28: 141–9.
  • Budtz-Jorgensen E, Bertram U. Denture stomatitis. II. The effect of antifungal and prosthetic treatment. Acta Odontol Scand 1970; 28: 283–304.
  • Olsen I. Denture stomatitis. Effects of chlorhexidine and amphotericin B on the mycotic flora. Acta Odontol Scand 1975; 33: 41–6.
  • Olsen I. Denture stomatitis. The clinical effects of chlorhexidine and amphotericin B. Acta Odontol Scand 1975; 33: 47–52.
  • Bergendal T, Isacsson G. Effect of nystatin in the treatment of denture stomatitis. Scand J Dent Res 1980; 88: 446–54.
  • Budtz-Jorgensen E, Holmstrup P, Krogh P. Fluconazole in the treatment of Candida-associated denture stomatitis. An-timicrob Agents Chemother 1988; 32: 1859–63.
  • Olsen I. Oral adhesion of yeasts. Acta Odontol Scand 1990; 48: 45–53.
  • Pendrak ML, Klotz SA. Adherence of Candida albicans to host cells. FEMS Microbiol Lett 1995; 129: 103–14.
  • Hazen KC, Hazen BW. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect Immun 1992; 60: 1499–508.
  • Yu L, Lee KK, Sheth H, et al. Fimbria-mediated adherence of Candida albicans to glycosphingolipid receptors on human buccal epithelial cells. Infect Immun 1994; 62: 2843–948.
  • Douglas U. Adhesion of pathogenic Candida species to host surfaces. Microbiol Sci 1985; 2: 243–7.
  • Samaranayake LP, MacFarlane TW. An in-vitro study of the adherence of Candida albicans to acrylic surfaces. Archs Oral Biol 1980; 25: 603–9.
  • McCourtie J, Douglas U. Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun 1981; 32: 1234–41.
  • Segal E, Kremer I, Dayan D. Inhibition of adherence of Candida albicans to acrylic by chitin derivative. Eur J Epi-demiol 1992; 8: 350–5.
  • Schmid J, Hunter PR, White GC, Nand AK, Cannon RD. Physiological traits associated with success of Candida albi-cans strains as commensal colonizers and pathogens. J Clin Microbiol 1995; 33: 2920–6.
  • Edgerton M, Scannapieco FA, Reddy MS, Levine MJ. Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immun 1993; 61: 244–52.
  • Nikawa H, Sadamori S, Hamada T, Okuda K. Factors involved in the adherence of Candida albicans and Candida tropicalis to protein-adsorbed surfaces. Micropathologia 1992; 118: 139–46.
  • Nikawa H, Iwanaga H, Kameda M, Hamada T. In vitro evaluation of Candida albicans adherence to soft denture-lin-ing materials. J Prosthet Dent 1992; 68: 804–8.
  • Vasilas A, Molina L, Hoffman M, Haidaris CG. The influence of morphological variation on Candida albicans adhe-sion to denture acrylic in vitro. Archs Oral Biol 1992; 37: 613–22.
  • Waters MGJ, Williams DW, Jagger RG, Lewis MAO. Adherence of Candida albicans to experimental denture soft lining materials. J Prosthet Dent 1997; 77: 306–12.
  • Nikawa H, Hayashi S, Nikawa Y, Hamada T, Samaranayake LP. Interactions between denture lining material, protein pellicles and Candida albicans. Archs Oral Biol 1993; 38: 631–4.
  • Edgerton M, Levine MJ. Characterization of acquired denture pellicle from healthy and stomatitis patients. J Prosthet Dent 1992; 68: 683–91.
  • Arendorf TM, Walker DM. Candida albicans: its association with dentures, plaque and the oral mucosa. J Dent Assoc Sth Afr 1980; 35: 563–9.
  • Branting C, Sund M-L, Linder LE. The influence of Strepto-coccus mutans on adhesion of Candida albicans to acryic surfaces in vitro. Archs Oral Biol 1989; 34: 347–53.
  • Hsu LY, Minah GE, Peterson DE, et al. Coaggregation of oral Candida isolates with bacteria from bone marrow trans-plant recipients. J Clin Microbiol 1990; 28: 2621–6.
  • Holmes AR, Gopal PK, Jenkinson HF. Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii. Infect Immun 1995; 63: 1827–34.
  • Grimaudo NJ, Nesbitt WE, Clark WB. Coaggregation of Candida albicans with oral Actinomyces species. Oral Micro-biol Immunol 1996; 11: 59–61.
  • Nair RG, Samaranayake LP. The effect of oral commensal bacteria on candidal adhesion to denture acrylic surfaces. APMIS 1996; 104: 339–49.
  • Verran J, Maryan CJ. Retention of Candida albicans on acrylic resin and silicone of different surface topography. J Prosthet Dent 1997; 77: 535–9.
  • Taylor R, Maryan C, Verran J. Retention of oral microorganisms on cobalt-chromium and dental acrylic resin with different surface finishes. J Prosthet Dent 1998; 80: 592–7.
  • Waltimo T, Tanner J, Vallittu P, Haapasalo M. Adherence of Candida albicans to the surface of polymethacrylate E-glass fiber composite used in dentures. Int J Prosthodont 1999; 12: 83–6.
  • Wendt S, Glass RT. The infected denture: how long does it take? Quintessence Int 1987; 18: 855–8.
  • Budtz-Jorgensen E. Denture stomatitis. III. Histopathology of trauma- and Candida-induced inflammatory lesions of the palatal mucosa. Acta Odontol Scand 1970; 28: 551–79.
  • Bergendal T, Isacsson G. A combined clinical, mycological and histological study of denture stomatitis. Acta Odontol Scand 1983; 41: 33–44.
  • Shakir BS, Martin MV, Smith C. Effect on experimental palatal candidosis in the Wistar rat of removal and reinser-tion of acrylic appliances. Archs Oral Biol 1986; 31: 617–21.
  • Shakir BS, Smith CJ, Martin MV. Epithelial mitotic activity during the induction of palatal candidosis in the Wistar rat. J Oral Pathol 1986; 15: 375–80.
  • Shepherd MG. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infec-tions. Infect Immun 1985; 50: 541–4.
  • Riichel R, de Bernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinases. J Med Vet Mycol 1992; 30 (suppl 1): 123–32.
  • Tsushima H, Mine H, Kawakami Y, Hyodoh F, Ueki A. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 1994; 140: 167–71.
  • Kaminishi H, Miyaguchi H, Tamaki T, et al. Degradation of humoral host defense by Candida albicans proteinase. Infect Immun 1995; 63: 984–8.
  • Sono E, Masuda T, Takesako K, et al. Comparison of secretory acid proteinases from Candida tropicalis, C. parap-silosis and C. albicans. Microbiol Immunol 1992; 36: 1099–104.
  • Wu T, Samaranayake LP. The expression of secreted as-partyl proteinases of Candida species in human whole saliva. J Med Microbiol 1999; 48: 711–20.
  • Wagner T, Borg-v Zeppelin M, Riichel R. pH-dependent denaturation of extracellular aspartic proteinases from Can-dida species. J Med Vet Mycol 1995; 33: 275–8.
  • Budtz-Jorgensen E. Proteolytic activity of Candida spp. as related to the pathogenesis of denture stomatitis. Sabourau-dia 1974; 12: 266–71.
  • Riichel R. A variety of Candida proteinases and their possible targets of proteolytic attack in the host. Zentralbl Bakte-riol Mikrobiol Hygiene 1984; A275: 266–74.
  • Reinholdt J, Krogh P, Holmstrup P. Degradation of IgAl, IgA2, and S-IgA by Candida and Torulopsis species. Acta Pathol Microbiol Scand Sect C: Immunology 1987; 95: 265–74.
  • Martin MV, Appleton J, Chesters J, Smalley JW. The effect of Candida albicans on the permeability of rat palatal epithe-1Mm: an ultrastructural and biochemical study. J Med Vet Mycol 1987; 25: 18–28.
  • Johannesen AC, Isacsson G, Nilsen R, Bergendal T. In situ characterization of the inflammatory cell infiltrates of hyper-plastic denture stomatitis. Acta Odontol Scand 1986; 44: 185–92.
  • Budtz-Jorgensen E. Immune response to Candida albicans in monkeys. Experimental candidiasis in the palatal mucosa. Scand J Dent Res 1973; 81: 360–71.
  • Budtz-Jorgensen E. Effects of triamcinolone acetonide on experimental oral candidiasis in monkeys. Scand J Dent Res 1975; 83: 171–8.
  • Ettinger RL. The etiology of inflammatory papillary hyper-plasia. J Prosthet Dent 1975; 34: 254–61.
  • Turrell AJW. Aetiology of inflamed upper denture-bearing tissues. Br Dent J 1966; 118: 542–6.
  • Bastiaan RJ. Denture sore mouth. Aetiological aspects and treatment. Austr Dent J 1976; 21: 375–82.
  • Blair Y, Bagg J, MacFarlane TW, Chestnutt I. Microbiological assessment of denture hygiene among patients in longstay and daycare community places. Community Dent Oral Epidemiol 1995; 23: 100–3.
  • Budtz-Jorgensen E, Loe H. Chlorhexidine as a denture disinfectant in the treatment of denture stomatitis. Scand J Dent Res 1972; 80: 457–64.
  • Lindquist L, Andrup B, Hedegärd B. Protesehygien II. Klinisk värdering av ett hygienprogram for patienter med protesstomatitt. Tandläkartidningen 1975; 67: 872–9.
  • Stafford GD, Arendorf GD, Huggett R. The effect of overnight drying and water immersion on candidal coloniza-tion and properties of complete dentures. J Dent 1986; 14: 52–6.
  • Andrup B, Andersson B, Hedegärd B. Protesehygien III. Räcker rengöring av helprotesen for stomatitutläkning Tandläkartidningen 1977; 69: 394–8.
  • Budtz-Jorgensen E, Kaaber S. Clinical effects of glazing denture acrylic resin bases using an ultraviolet curing method. Scand J Dent Res 1986; 94: 569–74.
  • Samaranayake LP, McCourtie L, MacFarlane TW. Factors affecting the in vitro adherence of Candida albicans to acrylic surfaces. Archs Oral Biol 1980; 25: 611–5.
  • Samaranayake LP, MacFarlane TW. The effect of dietary carbohydrates on the in vitro adherence of Candida albicans to epithelial cells. J Med Microbiol 1982; 15: 511–7.
  • Samaranayake YH, MacFarlane TW, Aitchison TC, Sama-ranayake LP. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral Microbiol Immunol 1993; 8: 177–81.
  • Nikawa H, Samaranayake LP, Hamada T. Modulation of the anti-Candida activity of apo-lactoferrin by dietary su-crose and tunicamycin in vitro. Archs Oral Biol 1995; 40: 581–4.
  • Russell C, Jones JH. The histology of prolonged candidal infection of the tongue. J Oral Pathol 1975; 4: 330–9.
  • Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose asociated with antibiotics, corticos-teroids and diabetes mellitus. J Infect Dis 1971; 123: 371–80.
  • Shuttleworth CW, Gibbs FJ. The aetiological significance of Candida albicans in chronic angular cheilitis and its treat-ment with nystatin. Br Dent J 1960; 108: 354–7.
  • Ritchie GM, Fletcher AM, Main DMG, Prophet AS. The etiology, exfoliative cytology, and treatment of denture stomatitis. J Prosthet Dent 1969; 22: 185–200.
  • Olsen I, Birkeland JM. Denture stomatitis - Yeast occur-rence and the pH of saliva and denture plaque. Scand J Dent Res 1977; 85: 130–4.
  • Schröder H. pH-Wert-Messungen unter Prothesen bei Pa-tienten mit Stomatitis prothetica. Dtsch Zahnärztl Z 1983; 38: 675–8.
  • Kleinberg I, Jenkins GN. The pH of dental plaques in the different areas of the mouth before and after meals and their relationship to the pH rate of flow of resting saliva. Archs Oral Biol 1964; 9: 493–516.
  • Narhi TO, Ainamo A, Meurman JH. Salivary yeasts, saliva, and oral mucosa in the elderly. J Dent Res 1993; 72: 1009–14.
  • Samaranayake LP, Reaside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22: 201–8.
  • Samaranayake LP, Huges A, MacFarlane TW. The prote-olytic potential of Candida albicans in human saliva. J Med Microbiol 1984; 17: 13–22.
  • Samaranayake LP, MacFarlane TW. Hypothesis: On the role of dietary carbohydrates in the pathogenesis of oral candidosis. FEMS Microbiol Lett 1985; 27: 1–5.
  • Totti MAG, Jorge AOC, dos Santos EB, de Almeida OP, Scully C. Implantation of Candida albicans and other Canspecies in the oral cavity of rats. J Oral Pathol Med 1996; 25: 308–10.
  • Navazesh M, Wood GJ, Brightman VJ. Relationship be-tween salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 284–8.
  • Tenovuo J. Nonimmunoglobulin defense factors in human saliva. In: Tenovuo J, ed. Human Saliva: Clinical Chemistry and Microbiology. Vol II. Boca Raton, FL: CRC Press, 1989: 55–91.
  • Sonkka T, Tenovuo J, Lenander-Lumikari M. Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol Lett 1992; 90: 223–8.
  • Lenander-Lumikari M. Inhibition of Candida albicans by the peroxidase/SCN/H202 system. Oral Microbiol Immunol 1992; 7: 315–20.
  • Lenander-Lumikari M, Johansson I. Effect of saliva compo-sition on growth of Candida albicans and Torulopsis glabrata. Oral Microbiol Immunol 1995; 10: 233–40.
  • Wu T, Samaranayake LP, Leung WK, Sullivan PA. Inhibi-tion of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol 1999; 48: 721–30.
  • Narhi TO, Tenovuo J, Ainamo A, Vilja P. Antimicrobial factors, sialic acid, and protein concentration in whole saliva of the elderly. Scand J Dent Res 1994; 102: 120–5.
  • Percival RS, Marsh PD, Challacombe SJ. Age-related changes in salivary antibodies to commensal oral and gut biota. Oral Microbiol Immunol 1997; 12: 57–63.
  • Jainkittivong A, Johnson DA, Yeh C-K. The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol Immunol 1998; 13: 181–7.
  • Hase JC, Birkhed D, Lagerlof F, Thornqvist E. Oral reten-tion of glucose at pharmacologically reduced salivary flow in man. Scand J Dent Res 1994; 102: 180–5.
  • Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol 1994; 31: S2–5.
  • Holbrook WP, Hjoleifsdottir DV. Occurrence of oral Can-dida albicans and other yeast-like fungi in edentulous pa-tients in geriatric units in Iceland. Gerodontics 1986; 2: 153–6.
  • Lockhart SR, Joly S, Vargas K, Swails-Wenger J, Euger L, Soli DR. Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J Dent Res 1999; 78: 857–68.
  • Challacombe SJ. Immunologic aspects of oral candidosis. Oral Surg Oral Med Oral Pathol 1994; 78: 202–10.
  • Morimoto K, Kihara A, Suetsugu T. Clinico-pathological study on denture stomatitis. J Oral Rehabil 1987; 14: 513–22.
  • Lehner T. Immunofluorescence study of Candida albicans in candidiasis, carriers and controls. J Pathol Bacteriol 1966; 91: 97–104.
  • Staib F, Schröder H, Mishra SK. Mykologische Befunde bei Stomatitis prothetica und ihre Beurteilung. Zbl Bakt Hyg I Abt Orig A 1982; 253: 131–9.
  • Ivanyi L, Wong WK. Elevated IgA salivary antibody levels to mycobacterial 65kDa stess protein in patients with oral candidosis. Folia Biologica 1992; 38: 263–8.
  • Lange K-P, Seyfarth M, Lorenz U. Immunologische Unter-suchungen zur Átiologie der Prothesenstomatopathien. Zahn-. Mund- u. Kieferheilkd. 1982; 70: 691–7.
  • Knak G, Lange K-P, Seyfarth M, Strupp K. Immunologi-sche Untersuchungen bei Patienten mit Stomatitis prothet-ica. Stomatol DDR 1983; 33: 401–7.
  • Epstein JB, Kimura LH, Menard TW, Truelove EL, Pearsall NN. Effects of specific antibodies on the interactions be-tween the fungus Candida albicans and human oral mucosa. Archs Oral Biol 1982; 27: 469–74.
  • Vudhichamnong K, Walker DM, Ryley HC. The effect of secretory immunoglobulin A on the in vitro adherence of the yeast Candida albicans to human oral epithelial cells. Archs Oral Biol 1982; 72: 617–21.
  • Shepherd MG. The pathogenesis and host defence mecha-nisms of oral candidosis. N Z Dent J 1986; 82: 78–81.
  • Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: Clearance, colonization, or candidiasis? J Dent Res 1995; 74: 1152–61.
  • Lacasse M, Fortier C, Chakir J, COM L, Deslauriers N. Acquired resistance and persistence of Candida albicans fol-lowing oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol Immunol 1993; 8: 313–8.
  • Shannon DC, Johnson G, Rosen FS, Austen KF. Cellular reactivity to Candida albicans antigen. New Engl J Med 1966; 275: 690–3.
  • Davenport JC, Wilton JMA. Incidence of immediate and delayed hypersensitivity to Candida albicans in denture stom-atitis. J Dent Res 1971; 50: 892–5.
  • Budtz-Jorgensen E. Cellular immunity in acquired candidia-sis of the palate. Scand J Dent Res 1973; 81: 372–82.
  • Syverson RE, Buckley H, Gibian J, Ryan GM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979; 134: 624–7.
  • Fidel PL, Sobel JD. Immunopathogenesis of recurrent vul-vovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335–48.
  • Ferrante A, Thong YH. The effect of amphotericin B treatment of Candida albicans-induced immunosuppression in mice. Immunol Lett 1980; 1: 321–3.
  • Rivas V, Rogers TJ. Studies on the cellular nature of Canalbicans-induced suppression. J Immunol 1983; 130: 376–9.
  • Scheutz F, Matee MI, Simon E, et al. Association between carriage of oral yeasts, malnutrition and HIV-1 infection among Tanzanian children aged 18 months to 5 years. Community Dent Oral Epidemiol 1997; 25: 193–8.
  • Mikhail MS, Palan PR, Basu J, Anyaegbunam A, Romney SL. Decreased beta-carotene levels in exfoliated vaginal ep-ithelial cells in women with vaginal candidiasis. Am J Rep Immunol 1994; 32: 221–5.
  • Bergman OJ, Andersen PL. Acute oral candidiasis during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis 1990; 22: 353–8.
  • Epstein JB, Komiyama K, Duncan D. Oral topical steroids and secondary oral candidiasis. J Oral Med 1986; 41: 223–7.
  • Tongprasom K, Luangjarmekorn L, Serenat T, Taweesao W. Relative efficacy of fluocinalone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992; 21: 456–8.
  • Bunetel L, Bonnaure-Mallet M. Oral pathoses caused by Candida albicans during chemotherapy. Update on develop-ment mechanisms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 161–5.
  • Deslauriers N, Coulombe C, Cane B, Goulet J-P. Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol 1995; 11: 45–56.
  • Enwonwu CO, Meeks VI. Oral candidiasis, and saliva gluco-corticoids. Am J Pathol 1996; 148: 13138.
  • Mishra SK, Segal E, Gunter E, et al. Stress, immunity and mycotic diseases. J Med Vet Mycol 1994; 32: 379–406.
  • Shah DT, Glover DD, Larsen B. In situ mycotoxin production by Candida albicans in women with vaginitis. Gynecol Obstet Invest 1995; 39: 67–9.
  • Silverman S, Luangjarmekorn L, Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med 1984; 39: 194–6.
  • Rossie KM, Taylor J, Beck FM, Hodgson SE, Blozis GG. Influence of radiation therapy on oral Candida albicans colonization: a quantitative assessment. Oral Surg Oral Med Oral Pathol 1987; 64: 698–701.
  • Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995; 33: 432–9.
  • Epstein JB, Freilich MM, Le ND. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 1993; 76: 169–74.
  • Budtz-Jorgensen E, Lombardi T. Antifungal therapy in the oral cavity. Periodontology 2000 1996; 10: 89–106.
  • Tattersall RB, Gale EAB. Diabetes-clinical management. Edinburgh: Churchill Livingstone, 1990: 386–464.
  • Peters RB. Candida albicans in the oral cavity of diabetics. J Dent Res 1966; 45: 771–7.
  • Johnston RD. Asymptomatic quantitative increase of Candida albicans in the oral cavity: predisposing conditions. Sth Med J 1967; 60: 1244–7.
  • Cawson RA. Chronic oral candidosis, denture stomatitis, and chronic hyperplastic candidosis. In: Winner HI, Hurley R, eds. Symposium on Candida Infections. Edinburgh: Liv-ingstone, 1966: 138–52.
  • Burman LR, Bartels NA, Bailey R. Oral moniliasis in a diabetic patient. J Oral Med 1966; 21: 177–9.
  • Tapper-Jones LM, Alred MJ, Walker DM, Hayes TM. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 24: 706–11.
  • Darwazeh AMG, Lamey PJ, Samaranayake LP, et al. The relationship between colonisation, secretor status and in-vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J Med Microbiol 1990; 33: 43–9.
  • Dorocka-Bobkowska B, Budtz-Jorgensen E, Wloch S. Non-insulin-dependent diabetes mellitus as a risk factor for den-ture stomatitis. J Oral Pathol Med 1996; 25: 411–5.
  • Ueta E, Osaki T, Yoneda K, Yamamoto T. Prevalence of diabetes mellitus in odontogenic infections and oral can-didiasis: an analysis of neutrophil suppression. J Oral Pathol Med 1993; 22: 168–74.
  • Seelig MS. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immuno-logical defenses. Bact Rev 1966; 30: 442–59.
  • Challacombe SJ. Immunology of oral candidosis. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis. Bris-tol, UK: Wright, 1990: 104–23.
  • Fisker AV, Schiott CR, Philipsen HP. Short-term oral candidiasis in rats with special reference to the site of infection. Acta Path Microbiol Immunol Scand Sect B 1982; 90: 49–57.
  • Hassan OE, Jones JH, Russel C. Experimental oral candidal infection in rats modified by cyclophosphamide medication. IRCS Med Sci 1985; 11: 927.
  • Allen CM, Beck FM, Lurie FA, Pinsky HM. Influence of tetracycline on number and size of candidal lesions of the dorsal rat tongue. Prog Clin Biol Res 1985; 181: 283–5.
  • Samonis G, Anastassiadou H, Dassiou M, Tselentis Y, Bodey GP. Effects of broad-spectrum antibiotics on colo-nization of gastrointestinal tracts of mice by Candida albi-cans. Antimicrob Agents Chemother 1994; 38: 602–3.
  • MacDonald TM, Beardon PHG, McGilchristet MM, Duncan ID, McKendrick AD, McDevitt DG. The risks of symptomatic vaginal candidiasis after oral antibiotic ther-apy. Q J Med 1993; 86: 419–24.
  • Lehner T, Ward RG. Iatrogenic oral candidiasis. Br J Dermatol 1970; 83: 161–6.
  • Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis. Bristol, UK: Wright, 1990: 66–103.
  • McKendrick AJW. Denture stomatitis and angular cheilitis in patients receiving long-term tetracycline therapy. Br Dent J 1968; 124: 412–7.
  • Heimdahl A, Mattsson T, Dahllof G, Lönnquist B, Ringden O. The oral cavity as a port of entry for local and systemic early infections in patients treated with bone marrow trans-plantation. Oral Surg Oral Med Oral Pathol 1989; 68: 711–6.
  • Working Party for the British Society for Antimicrobial Chemotherapy. Chemoprophylaxis for candidosis and asper-gillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemother 1993; 32: 5–21.